September 17, 2020
One in eight women in the United States will be diagnosed with breast cancer, making it the second most common cancer in women. You play an integral role in early detection by recommending regular screenings to your patients. Early detection through regular screening is key to a better outcome for your patients.
The National Committee for Quality Assurance (NCQA) now allows patients to be excluded from the Breast Cancer Screening (BCS) measure due to advanced illness and frailty. They acknowledge that measured services most likely would not benefit patients who are in declining health.
Review the BCS tip sheet to learn more about this HEDIS measure, including information that should be documented in a patient’s medical record, information that should be included in claims, and tips for talking with patients.
For more information and/or questions about this article, email ProviderClinicalConsulting@Premera.com.
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).